Drugstores Granted Class Status In TriCor Suit

Law360, New York (August 18, 2008, 12:00 AM EDT) -- A federal judge on Monday granted class status to drugstores and other outlets alleging that the makers of the anti-cholesterol drug TriCor prevented a generic version of the drug from reaching the market by filing a series of frivolous patent infringement lawsuits.

But the judge put on hold class certification for 18 states and the District of Columbia, which filed a similar case.

A move by Abbott Laboratories and Fournier Industrie et Sante to have both sets of litigation dismissed was denied.

Judge Sue L. Robinson...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.